ಮಹಿಳೆಯರ ಕ್ಯಾನ್ಸರ್
Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries
ಎಲ್ಲಿಗೆ ಹೋಗಬೇಕು
ಈ trial ಗೆ 1 ಆಸ್ಪತ್ರೆ ರೋಗಿಗಳನ್ನು ಸೇರಿಸಿಕೊಳ್ಳುತ್ತಿದೆ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative …
ಸ್ಪಾನ್ಸರ್: ಟಾಟಾ ಮೆಡಿಕಲ್ ಸೆಂಟರ್
NCT06816836 ಆನ್ ClinicalTrials.gov
ಲಾಸ್ಟ್ ಅಪ್ಡೇಟೆಡ್ ಆನ್ ದ ರಿಜಿಸ್ಟ್ರಿ 29 ಮೇ 2025 · ರೀಡ್ ಬೈ ಅಸ್ 20 ಅಕ್ಟೋಬರ್ 2026